NexImmune Inc. NexImmune Receives IND Clearance for Phase 1/2 trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome ND clearance enables…
SAN DIEGO, Oct. 10, 2019 /PRNewswire/ — Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create…
MIAMI, Oct. 2, 2019 /PRNewswire/ — Rapha Capital Management, LLC (https://www.raphacap.com), an investment management firm located in Miami, Florida, through Rapha Capital Investment…